Latest Property News

Desane Group Holdings reported a sharp FY26 profit decline as lower property revaluation gains and higher finance costs overwhelmed largely stable rental income. The ASX-listed property group enters FY27 with more cash, conservative gearing and two developments that now need to convert asset value into earnings.

Garda Property Group has agreed to sell its Heathwood industrial property for $17.5 million, 6.7% above its independent valuation. If the buyer secures finance, the sale will help cut drawn debt and take gearing lower alongside the previously announced Pinkenba disposal.

Neuren says its partner Acadia has received a US Notice of Allowance for a trofinetide patent that could protect weight-banded dosing through 28 March 2041. The patent has not yet formally issued, but the allowance could extend US protection by almost five years beyond the existing method-of-use patent.

Mithril Silver and Gold has lifted the higher-confidence portion of its Copalquin Target 1 resource to 464,000 ounces of gold equivalent, giving the Mexican project a stronger base for mine planning. The upgrade comes alongside a larger loss, substantial exploration spending and an auditor’s warning that further funding is needed to support the company’s going-concern status.

SciDev Limited (ASX:SDV) finished FY26 with a sharp annual earnings decline, but a leaner business and stronger second-half performance offer a potential reset. Revenue fell 17% and underlying EBITDA dropped 49%, while the company exited loss-making international operations and rebuilt net cash to $6.8 million.

Lycopodium has won an approximately A$42.9 million engineering and procurement contract for Endeavour Mining’s Assafo-Dibibango gold project in Côte d’Ivoire. Work has begun, but continued execution and full implementation remain conditional on Endeavour approving its final investment decision, expected before the end of 2026.

GDI Property Group (ASX:GDI) lifted FY26 Funds From Operations by 25% to $44.5 million while reducing gearing to 33% and maintaining its 5.00 cents per security distribution. The annual report also sets out a buyback of up to 5% of stapled securities, but says completing the programme may depend on further asset sales.

Sea Forest has reported a sharp lift in SeaFeed revenue during its first full year as an ASX-listed company, but remains loss-making as it funds production and market expansion. The methane-reduction specialist ended FY26 with $27.8 million in cash and term deposits and no borrowings.

Singular Health has signed a non-binding MOU to build and operate a medical imaging repository for Florida Medicaid, with approximately A$3.5 million of potential revenue subject to definitive agreements and delivery. The project could give its 3DICOM platform a state-funded infrastructure reference site, but recurring funding remains unassured.

Arena REIT delivered higher earnings, distributions and asset values in FY2026, but the failure of a major childcare tenant has forced a sharp reset in its near-term outlook. Edge Early Learning accounts for about 14% of rental income and is now in voluntary administration after missing rent.

Patrys has moved its injectable quetiapine program into human testing, while its FY2026 annual report warns the company will need further funding within 12 months. The company ended the year with $3.36 million in cash after raising capital and acquiring the RLS-2202 development program.

Cynata Therapeutics (ASX:CYP) has reported a $9.25 million loss, negative net assets and a material uncertainty over going concern after its two major clinical trials failed to demonstrate efficacy. The company has since cut its workforce to zero, shifted management to the board and secured a $600,000 R&D tax incentive loan while it considers the future of its Cymerus platform.